JPS6121618B2 - - Google Patents

Info

Publication number
JPS6121618B2
JPS6121618B2 JP58010017A JP1001783A JPS6121618B2 JP S6121618 B2 JPS6121618 B2 JP S6121618B2 JP 58010017 A JP58010017 A JP 58010017A JP 1001783 A JP1001783 A JP 1001783A JP S6121618 B2 JPS6121618 B2 JP S6121618B2
Authority
JP
Japan
Prior art keywords
acid
solution
butoxyphenylacetylhydroxamic
chlorinating agent
precipitating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP58010017A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59110655A (ja
Inventor
Misheru Furantsu
Andora Banche
Joruje Ranberan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Continental Pharma Inc
Original Assignee
Continental Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JPS6121618(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Continental Pharma Inc filed Critical Continental Pharma Inc
Publication of JPS59110655A publication Critical patent/JPS59110655A/ja
Publication of JPS6121618B2 publication Critical patent/JPS6121618B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP58010017A 1982-12-13 1983-01-26 ｐ−ブトキシフェニルアセチルヒドロキサム酸の製造方法 Granted JPS59110655A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU84530 1982-12-13
LU84530A LU84530A1 (fr) 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide

Publications (2)

Publication Number Publication Date
JPS59110655A JPS59110655A (ja) 1984-06-26
JPS6121618B2 true JPS6121618B2 (enExample) 1986-05-28

Family

ID=19730000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58010017A Granted JPS59110655A (ja) 1982-12-13 1983-01-26 ｐ−ブトキシフェニルアセチルヒドロキサム酸の製造方法

Country Status (7)

Country Link
US (1) US4534911A (enExample)
EP (1) EP0116182B2 (enExample)
JP (1) JPS59110655A (enExample)
AT (1) ATE21889T1 (enExample)
CA (1) CA1218675A (enExample)
DE (1) DE3365914D1 (enExample)
LU (1) LU84530A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0130160B1 (en) * 1983-06-22 1988-01-07 The Ohio State University Research Foundation Small particle formation
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
EP0885609A1 (en) * 1997-06-17 1998-12-23 Continental Pharma Incorporated Use of a pharmaceutical composition in the treatment of traumatic arthritis in horses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE600278A (fr) * 1960-02-18 1961-08-16 Basf Ag Procédé pour la production de N-aryl-N'-hydroxy-urées.
SU390074A1 (ru) * 1970-08-04 1973-07-11 Всесоюзный научно исследовательский , проектный институт механической обработки полезных ископаемых Способ получения алкилгидроксамовых
SU632690A1 (ru) * 1977-06-08 1978-11-15 Предприятие П/Я М-5245 Способ получени с7-с9-алкилгидроксамовых кислот
JPS5777646A (en) * 1980-10-31 1982-05-15 Kanto Kagaku Kk Preparation of hydroxamic acid

Also Published As

Publication number Publication date
EP0116182B1 (fr) 1986-09-03
EP0116182B2 (fr) 1989-12-27
CA1218675A (en) 1987-03-03
LU84530A1 (fr) 1984-10-22
DE3365914D1 (en) 1986-10-09
ATE21889T1 (de) 1986-09-15
EP0116182A1 (fr) 1984-08-22
JPS59110655A (ja) 1984-06-26
US4534911A (en) 1985-08-13

Similar Documents

Publication Publication Date Title
KR920003332B1 (ko) 에토포시드(Etoposide)제제의 제조방법
TWI234465B (en) Stable complexes of poorly soluble compounds
EP2405890B1 (en) Riluzole aqueous suspensions
TW201114766A (en) Pharmaceutical composition for a hepatitis C viral protease inhibitor
IE62921B1 (en) Self-emulsifying glasses
CN110464846B (zh) 一种美洛昔康组合物、制剂及其制备方法与应用
JP2001505910A (ja) 改良医薬組成物
US4927638A (en) Etoposide solutions
JPH04275222A (ja) 安定性を強化したピロキシカム溶液、およびその製造方法
US8536325B2 (en) Process for purifying guar
AT397460B (de) Verfahren zur herstellung eines pharmazeutischen trockenpräparates enthaltend ein diclofenac-salz
CN112451483B (zh) 一种棕榈酸帕利哌酮混悬液的制备方法
JPS6121618B2 (enExample)
US4772589A (en) Etoposide solution in NMP
HU199289B (en) Process for production of liofilized medical compositions containing derivatives of phenil-quinoline-carbonic acid
CA2412575C (en) Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
DE60131769T2 (de) Derivatisierte kohlenhydrate und ihre verwendung in festen verabreichungssystemen
JP3341766B2 (ja) 分岐鎖アミノ酸を含有する医薬用懸濁剤
JPH0283323A (ja) 安定な酪酸リボフラビン水溶液
JPH01213228A (ja) 水性懸濁点眼剤
KR900000513B1 (ko) 에토포사이드 경구 투여용 조성물의 제조방법
HK1161985B (en) Riluzole aqueous suspensions
JPH04221379A (ja) チアプロフェン酸又はその不溶性若しくは部分可溶性エステルとシクロデキストリン又はそれらの誘導体との新規な複合体
JPH05505802A (ja) 固体作用物質形の製法及びこうして得られた生成物
JPH01275527A (ja) 新規なトルナフテート含有外用製剤